Development of a NK cell expansion protocol for use in assessments of NK-targeting therapeutics.

The Neonatal Fc Receptor (FcRn) shows promising therapeutic potential in autoimmunity and other conditions.

Partnership with lab-on-a-chip startup will help simulate complex disease states and accelerate drug discovery.

Antibody Analytics' in-house SPR experts discuss our custom SPR assay services and answer FAQs!

The partnership promotes collaboration between universities and industries across life science.

Our CSO Dr Agapitos Patakas presents our in vitro T cell exhaustion model.

Research often targets the capabilities of T cells, but B cells also hold therapeutic potential.

We’re excited to work with an organisation that empowers Black ethnic minority workers.

Our Senior Study Scientist Dr Luke Muir talks B cells.

We are delighted to share that Antibody Analytics is shortlisted for Scotland’s Life Sciences Business Leadership Award 2024!

This week marks National Apprenticeship Week!

The risk of a brain drain from Scotland is ever present...

Antibody Analytics is pleased to welcome Paul McCluskey as our new Chair of the Board. This appointment follows our recent minority investment from NorthEdge, marking a significant phase in Antibody Analytics’ growth.

In this webinar, we present IndEx-2, our powerful in vitro cell-based platform engineered to modulate the expression of one or two target antigens across a range of biologically relevant levels.

Explore our SPR research poster which investigates the multi-specific modalities of immunotherapeutic molecules.

Antibody Analytics has secured a multi-million-pound investment from NorthEdge. Read on to find out more details.

Explore our research poster as we analyse the data from our new cell line development platform, IndEx-2.

In this series we get to know the person behind the lab coat and goggles. This month, we meet Study Scientist, Rhiannon Williams.

Explore our research poster modelling the tumour microenvironment featuring NK cells, macrophages and T cells.

Exploring the realm of biomedical research is quite the adventure, just ask Cameron Fyfe. He's studying for an MSc in Precision Medicine and Pharmacological Innovation and got the chance to roll up his sleeves and really get stuck in during a 12-week work placement with Antibody Analytics.

We interview Amy Nicol, alongside her mentor Holly Greggan and review Amy's time at Antibody Analytics during her internship.

Find out more about our new inducible cell line development model IndEx-2 by reading through our latest whitepaper.

In this series we get to know the person behind the lab coat and goggles. This month, we meet Study Scientist, Rebecca Bonner. 

In this webinar, we present our own human in vitro T cell exhaustion model that is suitable for the screening of immuno-modulatory molecules, bispecific T cell engagers and multi-functional modalities.

Whilst Rebecca was performing in Sister Act, the team from Antibody Analytics were there to support her across all five days of the live show. Here is a little bit more about what Rebecca had to say about the show.

We are thrilled to share with you the presentation delivered by our CSO, Dr Agapitos Patakas, at the prestigious PEGS Boston 2023 conference.

Antibody Analytics are proud to announce that we have been shortlisted for two Lanarkshire business awards! Best business 51+ Employees and a nomination for Elias Blyel as apprentice of the year

In this series we get to know the person behind the lab coat and goggles. This month, we meet Senior Study Manager, Fiona Miller. 

In this series we get to know the person behind the lab coat and goggles. This month, we meet Senior Study Scientist, Carolyn Rainer.

Our latest new development is the launch of our transformative inducible cell line development platform: IndEx-2.

The 29th of May – 2nd of June marks ‘Discovery Week’ here at Antibody Analytics. A chance for us to celebrate as a team and promote discovery throughout the wider industry. Since cutting the ribbon on the Discovery Centre in May 2022, we've achieved some amazing milestones, and we're excited to share them with you.

In this series we get to know the person behind the lab coat and goggles. First up, we meet Andrew Baron.

Antibody Analytics is proud to announce that we have been presented with a Gold Award in the North Lanarkshire Council Employee Charter for Fair Pay, Employ North Lanarkshire, and Be the Best.

We are engaged. We are enthusiastic. We are experts. And we are committed to making science a level playing field for all, irrespective of gender. 

Joining Antibody Analytics in November 2022, Lauren Brown is the newest addition to our Senior Study Management team.

Antibody Analytics is thrilled to announce that we have been shortlisted in Scotland's Life Sciences Annual Awards in the 'Innovation Pharma Services and Drug Discovery' category.

Antibody Analytics is excited to announce a strategic partnership with HistologiX who specialise in cellular and digital pathology services.

With so much to celebrate and 2023 right around the corner, what better time to reflect on our highlights from the past 12 months?

Antibody Analytics is dedicated to supporting young people in STEM through various learning opportunities. We recently welcomed two students from Brannock High School for a four-week work experience placement. Not only are the students looking to achieve an SQA qualification from this, but they'll also get a glimpse into the working world.

One of the easiest ways to make beautiful assays is to ensure that you have effectively considered what sensor chips, buffers and other reagents are right for the job. Choosing your sensor chip An important part of setting up an assay is to ensure that the correct chip is chosen before you start. Beginning with…

Like most analytical assays, the quality of the starting material can heavily influence the results obtained. Poor quality proteins, and the solutions they are formulated in, can adversely affect measurements and ultimately the data quality and/or the microfluidics of the system. 

Our Treg suppression assay formats are adaptable, using natural Tregs isolated from PBMCs, or induced Tregs expanded and differentiated from naïve CD4+ T cells.

Regulatory T cells (thymically and peripherally derived Treg) have critical roles in maintaining immune homeostasis and controlling aberrant/excessive responses to self and non-self antigens.

Antibody Analytics has established an in vitro T cell exhaustion model that can be used to assess candidate immunotherapeutics. Find out more about our unique approach.

Target cells are a critical component of immune cell effector assays. Whether investigating T cell dependent cellular cytotoxicity (TDCC) or antibody dependent cellular cytotoxicity (ADCC), we create engineered target cells uniquely suited for the evaluation of effector function and molecule specificity. But how do we achieve this and what are the principles we follow?

Successful approval of biological medicinal products in the EU and US requires characterisation of the biological product’s properties to enable the setting of specifications that control the molecule’s critical quality attributes (CQA) for release into the clinic and onto the market. Release specifications ensure manufacturing lot-to-lot consistency, product stability, and ultimately, patient safety. So, what are the main development considerations? We delve into these to future-proof your potency assays.

Phew! It’s been quite the year for us here at Antibody Analytics. Between opening our new facility, the Antibody Analytics Discovery Centre and welcoming a host of new faces to our team, it’s certainly been all systems go. While 2022 signifies growth in all areas of our organisation, we’re delighted that this has been recognised beyond our …

We’re always happy to offer a helping hand to the rising stars of the future and we recently welcomed Ambar Ramzan to the team on a 12-week placement, as part of her MSc in Precision Medicine and Pharmacological Innovation. “I completed my Master of Pharmacy in 2016 but after working in pharmacy for five years …

Antibody Analytics is dedicated to investing our time and resources into developing young people in STEM. We recently engaged with Career Ready, a charity which works with employers, schools, and volunteers to support young people across the UK to advance in their careers through two year mentorship scheme. Thanks to the Career Ready programme, we...

A new Discovery Centre dedicated to the advancement of medical research and drug development opened its doors in Motherwell as part of a major expansion by a leading health sciences company. The unveiling of the new Antibody Analytics Discovery Centre, funded in part with support from Scottish Enterprise, will act as the springboard for the…

As you might have heard through the grape vine, this year, we’ve had the opportunity to offer not one, not two, but three research and development secondments. We’ve sat down with Kieran Izzett to dive deep into his experience of a culture dedicated to the research revolution. “What is life?” often crosses my mind. I ...

“How did it all begin? I studied for an undergraduate degree in Immunology at the University of Glasgow. When I graduated in 2001, I did what many aspiring scientists do; I put on my lab coat to get some hands on experience in a proper lab. “I took my knowledge of the immune system and …

To celebrate our continual growth, we sat down with the team to see what ignited the move from academia to Antibody Analytics.

As you’ve probably heard, Antibody Analytics is expanding, and so is our development opportunities. To celebrate our growth, we’ve sat down with a very talented lady who, with her hard work and determination, has attained a secondment in the Research and Development (R&D) department. Amy Graham has taken opportunities in her stride and injected enthusiasm…

As agents of change, we’ve switched things up in the laboratory. To celebrate this period of change, we’ve sat down with Hannah Findlay to see how her secondment into the Research and Development (R&D) department aligns with the continual growth of Antibody Analytics.

The 11th of March 2022 marks the start of British Science Week, a ten-day celebration of science, technology, engineering, and maths (STEM). This year, the theme is ‘growth,’ so it's only fitting that we take you on a journey from the bench to the bedside and beyond.

The Antibody Analytics journey begins with its Managing Director, Andy Upsall. As the organisation continues to grow, we aim to understand the origins of Antibody Analytics and what led Andy to establish the company in 2016.

With a flair for the human body and the way in which it works, we seek to discover how Rebecca’s diploma in Professional Music Theatre do-si-doed into a technical apprenticeship in the field of science.

Friday the 11th of February marks the International Day of Women and Girls in Science. During this historic day, people around the world are recognising the role of women and girls in the field of science, not only as beneficiaries but as agents of change.

Considering Tim’s vast experience in molecular biology, wonder for the wider world and what makes things the way that they are, its believed Tim’s path led him to Antibody Analytics because of his intrigue and desire to provide a genuine impact in the field of medicine.

With a degree in applied psychology and experience in the social care sector, we seek to discover how Michahaila found herself in the scientific field and what this means as the Director of People and Finance.

With a PhD and post-doctoral experience as a cancer research scientist, we aim to understand Adele’s journey from the field of research and development to the Director of Marketing at Antibody Analytics.

Antibody Analytics are pleased to announce that they have been awarded a coveted and highly competitive SMART grant from Innovate UK, the UK’s innovation agency.

The population of effector cells used in cell-based cytotoxicity assays such as TMC is an important consideration. Depending on how sensitive or therapeutically relevant your assay needs to be will dictate what sort of effector preparation should be used. The more sensitive an assay system (through the use of less clinically relevant effector cell preparations)…